2025 Free
MS Society · London, UK

Stop MS Appeal Impact Report

The MS Society's Stop MS Appeal Impact Report marks the close of its ten-year appeal, which raised over £101.9 million to fund research into multiple sclerosis. Over ten years the appeal supported 26 clinical trials and 171 research projects, leveraged £12.9 million from partner organisations, and backed 457 publications. The report covers the Octopus trial, the first multi-arm, multi-stage trial for progressive MS, which expanded to new sites across the UK in 2025; the MS Society Tissue Bank; the UK MS Register; Centres of Excellence in Edinburgh and Cambridge; and the International Progressive MS Alliance.

Report snapshot
3 Views

About

The MS Society is the UK's multiple sclerosis charity. It funds research, supports people living with MS and campaigns for better treatment and services. Its Stop MS Appeal set out to raise £100 million for research to find treatments for everyone with MS, including progressive forms of the condition.

Key Metrics

£101.9 million raised by the Stop MS Appeal for MS research (over)
26 clinical trials supported over 10 years
171 research projects funded

Key Outcomes

  • The Octopus trial, the first ever multi-arm, multi-stage trial for progressive MS, expanded to new sites across the UK in 2025, with two treatments already being tested.
  • 4,426 people with MS are registered as MS Society Tissue Bank donors and 855 brains have been donated to research.
  • Over 50,000 people, a third of the UK MS population, have provided data to the UK MS Register.

Geography

UK-Wide

Impact Snapshot
Key Metric 1
Total income £18,180,000 and total expenditure £18,560,000 (year ended 31 December 2024, charity no. 1084958 England/Wales and SC039654 Scotland); in 2024 spent £3.8m on...
Key Metric 2
700+ members supported through in-person visits and support calls in 2025; 697 support grants allocated in 2025 for essential items including specialist clothing, cooling...
Key Metric 3
Largest global investment in EB research to date: multi-million-pound drug repurposing trial provisionally agreed with LifeArc partner at Guy's and St Thomas' NHS Foundation...
£34,000 raised in 2025 winter appeal supporting families like Darcie's with specialist items, emotional support and research; 697 support grants delivered in 2025; first Members Connect event in Northern Ireland; EB Priorities Setting Partnership study completed providing global research roadmap
Impact Snapshot
Key Metric 1
22,507 households helped through RBL casework and specialist support services across 66 countries
Key Metric 2
22,600 grants given to those in need, totalling £11.8 million
Key Metric 3
733 beneficiaries represented at tribunals, resulting in £24.5 million in War Pensions awards
1,548 new families living with dementia supported by RBL Admiral Nurses service
Impact Snapshot
Key Metric 1
3,600 blind veterans received support across the UK; 447 new blind veterans started receiving support in 2024/25
Key Metric 2
1,598 referrals to rehabilitation services completed; 313 veterans received assistive technology training
Key Metric 3
997 volunteers donated 26,824 hours of support; befriending service awarded Quality in Befriending Excellence — one of only 11 organisations in the UK to...
1,831 National Creative Wellbeing Project packs issued to help veterans reconnect with creativity and independence
Impact Snapshot
Key Metric 1
349,000+ people completed the Know Your Risk tool to assess their risk of type 2 diabetes in 2024
Key Metric 2
£4 million invested in 17 new research projects; total active grants portfolio worth over £45 million
Key Metric 3
32% of people completing NHS England's Path to Remission programme — which Diabetes UK campaigned for — put their type 2 diabetes into remission
Type 1 Diabetes Grand Challenge invested over £23 million in 19 projects across 161 experts from 47 institutions in 8 countries since 2022